Patent: 4,438,198
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 4,438,198
Title: | Biochemically active matrix for use in a bio-artificial organ |
Abstract: | A biochemically active matrix for use in a bio-artificial organ is disclosed. The biochemically active matrix has an enzyme covalently bonded to a matrix of organochemically cross-linked fibrin. The matrix may be suspended in a medium of agarose which irreversibly solidifies below 37.degree. C. The bio-artificial organ is useful for extracorporeal treatment of blood to remove excess substrate from the blood. . |
Inventor(s): | Schmer; Gottfried (Seattle, WA) |
Assignee: | Trimedyne, Inc. (Arlington Heights, IL) |
Application Number: | 06/307,073 |
Patent Claims: | see list of patent claims |
Details for Patent 4,438,198
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | See Plans and Pricing | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |